- Amnestic syndrome of the subcallosal artery: a novel infarct syndromeMichael Moussouttas
New Jersey Neuroscience Institute, JFK Medical Center, Seton Hall University, Edison, NJ, USA
Cerebrovasc Dis 19:410-4. 2005
- Prevalence, timing, risk factors, and mechanisms of anterior cerebral artery infarctions following subarachnoid hemorrhageMichael Moussouttas
Cerebrovascular and Critical Care Division, Department of Neurology, Thomas Jefferson University Medical Center, 900 Walnut Street, Suite 200, Philadelphia, PA 19107, USA
J Neurol 260:21-9. 2013..046) again predicted PI. Clinical severity/grade and ACA/ACom aneurysm location are the most consistent predictors of ACA infarctions. Vasospastic and non-vasospastic processes may concurrently contribute to ACA infarcts...
- Cerebrospinal fluid catecholamine levels as predictors of outcome in subarachnoid hemorrhageMichael Moussouttas
Cerebrovascular and Neurocritical Care Division, Thomas Jefferson Medical Center, Philadelphia, PA, USA
Cerebrovasc Dis 33:173-81. 2012..The purpose of this study is to determine whether early central catecholamine levels measured from cerebrospinal fluid (CSF) relate to outcome in patients with SAH...
- Determinants of central sympathetic activation in spontaneous primary subarachnoid hemorrhageMichael Moussouttas
Cerebrovascular and Neurocritical Care Division, Department of Neurology, Thomas Jefferson Medical Center, 900 Walnut Street, Suite 200, Philadelphia, PA 19107, USA
Neurocrit Care 16:381-8. 2012..The purpose of this investigation is to identify demographic, clinical, radiological, and anatomical features of SAH that relate to sympathetic activation...
- Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhageMichael Moussouttas
Division of Cerebrovascular and Critical Care Neurology, Thomas Jefferson Medical Center, 900 Walnut Street, Suite 200, Philadelphia, PA 19107, USA
Neurocrit Care 12:24-9. 2010..The purpose of this study was to determine whether the reported use of antiplatelet agents also results in greater hematoma expansion...
- Cerebrovascular disease among patients from the Indian subcontinentM Moussouttas
Department of Neurology, NJ Neuroscience Institute, Seton Hall University, South Orange, NJ, USA
Neurology 67:894-6. 2006..SA patients experienced a 75% lower risk of cardiogenic infarctions, but a threefold increased risk of intracranial atherothrombosis. Risk factor modifications and secondary prevention strategies may differ for SA patients...
- Eclamptic subarachnoid haemorrhage without hypertensionMichael Moussouttas
NJ Neuroscience Institute, JFK Medical Center, Edison, New Jersey 08818, USA
J Clin Neurosci 13:474-6. 2006..Treatment consisted only of nimodipine for the prevention of vasospasm. The patient made an excellent recovery, without residual neurological deficits...
- Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestationsM Moussouttas
Department of Neurology, Yale University School of Medicine, New Haven, CT 06520, USA
Neurology 55:959-64. 2000..PAVM occur in 20 to 30% of the hereditary hemorrhagic telangiectasia (HHT) population...
- Fulminant acute inflammatory demyelinating polyradiculoneuropathy: case report and literature reviewMichael Moussouttas
Department of Neurology, New York Medical College, USA
Neurocrit Care 1:469-73. 2004..Fulminant cases of total body paralysis with loss of all cranial nerve reflexes have been described, whereby patients appear to have lost all central nervous system (CNS) function...
- Combination antiplatelet agents in ischemic cerebrovascular diseaseMichael Moussouttas
Cerebrovascular Division, Department of Neurology, Seton Hall University, South Orange, NJ, USA
Mt Sinai J Med 72:16-22. 2005..Combination therapy with aspirin and clopidogrel seems to increase the risk of major hemorrhages, whereas aspirin plus xrDP does not. Ongoing trials are expected to clarify the role of various combination antiplatelet regimens...
- Cannabis use and cerebrovascular diseaseMichael Moussouttas
Department of Neurology, New York Medical College, Valhalla, NY, USA
Neurologist 10:47-53. 2004..However, cases of acute onset neurologic dysfunction occurring in relation to cannabis use have been described and corresponding cerebral imaging studies have documented focal ischemic changes and vessel abnormalities...
- Intravascular lymphomatosis presenting as posterior leukoencephalopathyMichael Moussouttas
Department of Neurology, New York Medical College, Valhalla, NY, 10595 USA
Arch Neurol 59:640-1. 2002
- Impact of intraventricular hemorrhage upon intracerebral hematoma expansionMichael Moussouttas
Division of Cerebrovascular and Neurocritical Care, Thomas Jefferson Medical Center, Philadelphia, PA 19107, USA
Neurocrit Care 14:50-4. 2011..The purpose of this study is to determine whether intraventricular hemorrhage (IVH) exerts a "decompressive" effect that limits intracerebral hemorrhage (ICH) enlargement...
- CSF catecholamine profile in subarachnoid hemorrhage patients with neurogenic cardiomyopathyMichael Moussouttas
Cerebrovascular and Neurocritical Care Division, Thomas Jefferson Medical Center, 900 Walnut Street, Suite 200, Philadelphia, PA 19107, USA
Neurocrit Care 14:401-6. 2011..The purpose of this research is to determine whether cerebrospinal fluid (CSF) catecholamine levels are elevated in subarachnoid hemorrhage (SAH) patients with NC when compared to those without NC...
- Association between sympathetic response, neurogenic cardiomyopathy, and venous thromboembolization in patients with primary subarachnoid hemorrhageMichael Moussouttas
Neurocritical Care Division, Capital Institute for Neuroscience, Capital Regional Medical Center, 750 Brunswick Avenue, Trenton, NJ 08638, USA
Acta Neurochir (Wien) 155:1501-10. 2013..This investigation will assess whether catecholaminergic activity relates to venous thrombotic events in patients with acute SAH...
- Hospital mortality in primary admissions of septic patients with status epilepticus in the United States*Jacqueline Urtecho
1Division of Critical Care and Neurotrauma, Department of Neurology, Thomas Jefferson University, Philadelphia, PA 2Division of Critical Care and Neurotrauma, Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA 3Department of Medicine, Thomas Jefferson University, Philadelphia, PA 4Division of Cerebrovascular Diseases, Thomas Jefferson University, Philadelphia, PA 5Division of Biostatistics, The Rothman Institute, Philadelphia, PA
Crit Care Med 41:1853-62. 2013..To determine the prevalence of status epilepticus, associated factors, and relationship with in-hospital mortality in primary admissions of septic patients in the United States...
- Thunderclap headache with normal CT and lumbar puncture: further investigations are unnecessary: againstMichael Moussouttas
Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, PA, USA
Stroke 39:1394-5. 2008
- Impact of acute lung injury and acute respiratory distress syndrome after traumatic brain injury in the United StatesFred Rincon
Department of Neurology, Division of Critical Care, Thomas Jefferson University, Jefferson College of Medicine, Philadelphia, Pennsylvania 19107, USA
Neurosurgery 71:795-803. 2012..Traumatic brain injury (TBI) is a major cause of disability, morbidity, and mortality. The effect of the acute respiratory distress syndrome and acute lung injury (ARDS/ALI) on in-hospital mortality after TBI remains controversial...
- Perioperative stroke after total joint arthroplasty: prevalence, predictors, and outcomeS M Javad Mortazavi
Rothman Institute of Orthopedics, Thomas Jefferson University Hospital, 925 Chestnut Street, Philadelphia, PA 19107, USA
J Bone Joint Surg Am 92:2095-101. 2010..In addition, risk factors for the development of this complication were evaluated in an attempt to identify a strategy that could minimize the prevalence of this complication...
- Metabolic syndrome: contributing factors and treatment strategiesSusan B Fowler
University of Medicine and Dentistry of New Jersey School of Nursing, The University Hospital, Newark, NJ, USA
J Neurosci Nurs 37:220-3. 2005....
- Emerging therapies: ESPRITMichael Moussouttas
Stroke 38:1142. 2007
- Emerging therapies: clopidogrel and aspirinMichael Moussouttas
Stroke 36:707. 2005